Determination of Optimal Sample Size for Quantification of β-Cell Area, Amyloid Area and β-Cell Apoptosis in Isolated Islets

Journal of Histochemistry and Cytochemistry

Volumn 63, Issue 8, 2015, Pages 663-673

  Meier, Daniel T ^a   Entrup, Leon ^a   Templin, Andrew T ^a   Hogan, Meghan F ^a   Samarasekera, Thanya ^a   Zraika, Sakeneh ^a   Boyko, Edward J ^a   Kahn, Steven E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

amyloid; apoptosis; histology; immunohistochemistry; insulin; islet isolation; pancreatic islet; staining; cell

Indexed keywords

AMYLIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCULATION; CONTROLLED STUDY; CYTOMETRY; FEMALE; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAMPLE SIZE; ANIMAL; C57BL MOUSE; CYTOLOGY; MALE; TRANSGENIC MOUSE;

RODENTIA;

ANIMALS; APOPTOSIS; FEMALE; INSULIN-SECRETING CELLS; ISLET AMYLOID POLYPEPTIDE; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SAMPLE SIZE;

EID: 84938390497     PISSN: 00221554     EISSN: 15515044     Source Type: Journal    
DOI: 10.1369/0022155415585995     Document Type: Article

References (32)

1. K.Aston-MourneyR.L.HullS.ZraikaJ.UdayasankarS.L.SubramanianS.E.Kahn (2011). Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets. Diabetologia54:1756-1765.
2. K.Aston-MourneyS.ZraikaJ.UdayasankarS.L.SubramanianP.S.GreenS.E.KahnR.L.Hull (2013). Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide. J Biol Chem288:3553-3559.
3. J.D.BagdadeE.L.BiermanD.PorteJr (1967). The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest46:1549-1557.
4. M.BrissovaM.J.FowlerW.E.NicholsonA.ChuB.HirshbergD.M.HarlanA.C.Powers (2005). Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem53:1087-1097.
5. M.ChintinneG.StangeB.DenysP.In ‘t VeldK.HellemansM.Pipeleers-MarichalZ.LingD.Pipeleers (2010). Contribution of postnatally formed small beta cell aggregates to functional beta cell mass in adult rat pancreas. Diabetologia53:2380-2388.
6. Y.DorJ.BrownO.I.MartinezD.A.Melton (2004). Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature429:41-46.
7. A.K.FoulisC.N.LiddleM.A.FarquharsonJ.A.RichmondR.S.Weir (1986). The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia29:267-274.
8. C.E.GleasonM.GonzalezJ.S.HarmonR.P.Robertson (2000). Determinants of glucose toxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15. Am J Physiol Endocrinol Metab279:E997-E1002.
9. M.L.GolsonW.S.BushM.Brissova (2014). Automated quantification of pancreatic beta-cell mass. Am J Physiol Endocrinol Metab306:E1460-E1467.
10. P.A.Halban (2004). Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine. Nat Cell Biol6:1021-1025.
11. H.J.HiddingaS.SakagashiraM.IshigameP.MaddeT.SankeK.NanjoY.C.KudvaJ.J.LeeJ.van DeursenN.L.Eberhardt (2012). Expression of wild-type and mutant S20G hIAPP in physiologic knock-in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance. J Diabetes Investig3:138-147.
12. H.E.HohmeierC.B.Newgard (2004). Cell lines derived from pancreatic islets. Mol Cell Endocrinol228:121-128.
13. D.J.W.M.HöppenerDr. J. W. MJ.S.VerbeekE.J.P.de KoningC.OosterwijkK.L.van HulstH.J.Visser-VernooyF.M.A.HofhuisS.van GaalenM.J.H.BerendsW.H.L.HackengH.S.JanszJ.F.MorrisA.ClarkP.J.A.CapelC.J.M.Lips (1993). Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia36:1258-1265.
14. J.JansonW.C.SoellerP.C.RocheR.T.NelsonA.J.TorchiaD.K.KreutterP.C.Butler (1996). Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A93:7283-7288.
15. C.A.JurgensM.N.ToukatlyC.L.FlignerJ.UdayasankarS.L.SubramanianS.ZraikaK.Aston-MourneyD.B.CarrP.WestermarkG.T.WestermarkS.E.KahnR.L.Hull (2011). beta-cell loss and beta-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol178:2632-2640.
16. S.E.KahnR.L.PrigeonD.K.McCullochE.J.BoykoR.N.BergmanM.W.SchwartzJ.L.NeifingW.K.WardJ.C.BeardJ.P.Palmer (1993). Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes42:1663-1672.
17. G.KlöppelC.DrenckA.CarstensenP.Heitz (1984). The B cell mass at the clinical onset of type I diabetes. Behring Inst Mitt75:42-49.
18. G.KloppelM.LohrK.HabichM.OberholzerP.U.Heitz (1985). Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res4:110-125.
19. D.S.LiY.H.YuanH.J.TuQ.L.LiangL.J.Dai (2009). A protocol for islet isolation from mouse pancreas. Nat Protoc4:1649-1652.
20. D.L.MacArthurE.J.de KoningJ.S.VerbeekJ.F.MorrisA.Clark (1999). Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets. Diabetologia42:1219-1227.
21. N.MacleanR.F.Ogilvie (1955). Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes4:367-376.
22. J.NerupO.AndersenG.BendixenJ.EgebergR.GunnarssonH.KromannJ.Poulsen (1974). Cell-mediated Immunity in Diabetes Mellitus. Proc R Soc Med67:506-513.
23. L.OrciD.BaetensC.RufenerM.AmherdtM.RavazzolaP.StuderF.Malaisse-LagaeR.Unger (1976). Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci U S A73:1338-1342.
24. P.Schwartz (1970). Amyloidosis; cause and manifestation of senile deterioration, Springfield: Charles C. Thomas.
25. S.L.SubramanianR.L.HullS.ZraikaK.Aston-MourneyJ.UdayasankarS.E.Kahn (2012). cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets. Diabetologia55:166-174.
26. C.B.VerchereD.A.D’AlessioR.D.PalmiterG.C.WeirS.Bonner-WeirD.G.BaskinS.E.Kahn (1996). Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A93:3492-3496.
27. F.WangR.L.HullJ.VidalM.CnopS.E.Kahn (2001). Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Diabetes50:2514-2520.
28. G.T.WestermarkS.Gebre-MedhinD.F.SteinerP.Westermark (2000). Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol Med6:998-1007.
29. P.WestermarkU.EngstromK.H.JohnsonG.T.WestermarkC.Betsholtz (1990). Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A87:5036-5040.
30. S.ZraikaK.Aston-MourneyP.MarekR.L.HullP.S.GreenJ.UdayasankarS.L.SubramanianD.P.RaleighS.E.Kahn (2010). Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation. J Biol Chem285:18177-18183.
31. S.ZraikaR.L.HullJ.UdayasankarK.Aston-MourneyS.L.SubramanianR.KisilevskyW.A.SzarekS.E.Kahn (2009). Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia52:626-635.
32. S.ZraikaR.L.HullJ.UdayasankarK.M.UtzschneiderJ.TongF.GerchmanS.E.Kahn (2007). Glucose- and time-dependence of islet amyloid formation in vitro. Biochem Biophys Res Commun354:234-239.